NCT00065130已完成3 期
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 2
- 主要终点
- Postprandial glycemic control
研究概览
简要总结
This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Subjects older than 35 years old will be considered
- •Gestational diabetes mellitus
排除标准
- 未提供
结局指标
主要结局
Postprandial glycemic control
次要结局
- Hypoglycemic episodes
- Adverse events
- HbA1c (glycosylated haemoglobin A1c)
- Postprandial endogenous insulin secretory response
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsDiabetesDiabetes Mellitus, Type 1NCT00097071Novo Nordisk A/S299
已完成
3 期
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesDiabetesDiabetes Mellitus, Type 1NCT01831765Novo Nordisk A/S1,290
已完成
4 期
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesDiabetes Mellitus, Type 2DiabetesNCT00274274Novo Nordisk A/S373
已完成
1 期
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy VolunteersHealthyDiabetesNCT01487811Novo Nordisk A/S50
已完成
3 期
Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyDiabetes Mellitus, Type 2DiabetesNCT00598793Novo Nordisk A/S242